|
Volumn 132, Issue 5, 1998, Pages 827-829
|
Pulmonary toxic associated with nitric oxide in term infants with severe respiratory failure
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
3 NITROTYROSINE;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERLEUKIN 1;
INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
NITRIC OXIDE;
OXYGEN;
TYROSINE DERIVATIVE;
UNCLASSIFIED DRUG;
VASODILATOR AGENT;
3-NITROTYROSINE;
CYTOKINE;
DRUG DERIVATIVE;
TYROSINE;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYTOKINE RELEASE;
DISEASE ASSOCIATION;
DISEASE COURSE;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INFANT;
LIPID PEROXIDATION;
LUNG TOXICITY;
LUNG VENTILATION;
MALE;
NEWBORN;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
RESPIRATORY FAILURE;
ARTIFICIAL VENTILATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DRUG EFFECT;
METABOLISM;
NEONATAL RESPIRATORY DISTRESS SYNDROME;
PERSISTENT FETUS CIRCULATION;
PROSPECTIVE STUDY;
CYTOKINES;
FEMALE;
HUMANS;
INFANT, NEWBORN;
LIPID PEROXIDATION;
MALE;
NITRIC OXIDE;
PERSISTENT FETAL CIRCULATION SYNDROME;
PROSPECTIVE STUDIES;
RESPIRATION, ARTIFICIAL;
RESPIRATORY DISTRESS SYNDROME, NEWBORN;
TYROSINE;
|
EID: 0031596843
PISSN: 00223476
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-3476(98)70312-9 Document Type: Article |
Times cited : (33)
|
References (14)
|